The cellular attachment and entry of human enterovirus 71: the role of glycosaminoglycans and evidence for a second receptor

QR Code

The cellular attachment and entry of human enterovirus 71: the role of glycosaminoglycans and evidence for a second receptor

Bibliographic Details
Main Authors:	Williams, David, Sioofy, A., Goodfellow, I., MacKenzie, John, Evans, David
Other Authors:	NA
Format:	Conference Paper
Published:	University of Wisconsin 2009
Online Access:	http://hdl.handle.net/20.500.11937/41413

Similar Items

Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor
by: Tan, Chee Wah, et al.
Published: (2013)

Molecular docking of SP40 peptide towards cellular receptors for enterovirus 71 (EV-A71)
by: Masomian, Malihe *, et al.
Published: (2021)

Virology, epidemiology, pathogenesis, and control of enterovirus 71.
by: Solomon, Tom, et al.
Published: (2010)

Flavivirus entry : cellular receptor utilization.
by: Chee, Hui Yee
Published: (2012)

Identification of mimotopes of human enterovirus 71
by: Yee, Siew Fung.
Published: (2007)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

Analysis of the role of DAF in the uncoating of DAF-binding enteroviruses
by: Williams, David, et al.
Published: (2005)

Investigation of the Role of Cell Surface Carbohydrates in Binding and Infection of Group A Human Enteroviruses
by: Diviney, Sinead, et al.
Published: (2009)

Incorrect identification of recent Asian strains of Coxsackievirus A16 as human enterovirus 71: Improved primers for the specific detection of human enterovirus 71 by RT PCR
by: David, Perera, et al.
Published: (2004)

Development of novel vaccines against Enterovirus-71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2015)

Clinical features, diagnosis, and management of enterovirus 71
by: Ooi, Mong How, et al.
Published: (2010)

Interactions of decay-accelerating factor (DAF) with haemagglutinating human enteroviruses: utilizing variation in primate DAF to map virus binding sites
by: Williams, David, et al.
Published: (2009)

Beta-actin variant is necessary for Enterovirus 71 replication
by: Lui, Edmund Yan Long, et al.
Published: (2013)

Impact of genetic changes in the Enterovirus 71 genome on virulence
by: Poh, Chit Laa *, et al.
Published: (2019)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Development of a Deoxyribonucleic Acid Vaccine Against Enterovirus 71
by: Wong, Siew Tung
Published: (2005)

Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

T Cell immunity to enterovirus 71 infection in humans and implications for vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2018)

Recombinant human enterovirus 71 in hand, foot and mouth disease patients
by: Yoke, Fun Chan, et al.
Published: (2004)

Factors affecting expression and solubility of Enterovirus 71 VP1 protein
by: Ahmad Hafad, Fathimah Azzahroh
Published: (2016)

The expression of recombinant bacille calmette-guerin (rBCG) containing VPI gene of enterovirus 71 (EV71)
by: Wey, Goh Kai
Published: (2008)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71
by: Pourianfar, Hamid Reza, et al.
Published: (2012)

Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach
by: Kirk, Kristin, et al.
Published: (2012)

AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication
by: Yogarajah, Thinesshwary, et al.
Published: (2017)

Impact of genetic changes, pathogenicity and antigenicity on Enterovirus- A71 vaccine development
by: Yee, Isabel Pin Tsin *, et al.
Published: (2017)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Development of a diagnostic tool for the detection of antibodies against human enterovirus 71
by: Tan, Cheng Siang.
Published: (2004)

Immunogenicity of soluble enterovirus 71 recombinant VP1 protein in mice model
by: Mustafa, Suhaili
Published: (2017)

A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Tan, Le Van, et al.
Published: (2015)

A generic assay for whole-genome amplification and deep sequencing of enterovirus A71
by: Le Van, Tan, et al.
Published: (2015)

Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years
by: Yuwana, Podin, et al.
Published: (2006)

The zoonotic flaviviruses of southern, south-eastern and eastern Asia, and Australasia: the potential for emergent viruses
by: MacKenzie, John, et al.
Published: (2009)

Flaviviruses
by: MacKenzie, John, et al.
Published: (2011)

A generic assay for whole-genome amplification and deep sequencingof enterovirus A71
by: Le, Van Tan, et al.
Published: (2015)

Human Enterovirus 71 Disease in Sarawak, Malaysia: A Prospective Clinical, Virological, and Molecular Epidemiological Study
by: Mong, How Ooi, et al.
Published: (2007)

Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines
by: Yogarajah, Thinesshwary, et al.
Published: (2016)

In Enterovirus 71 Encephalitis With Cardio-Respiratory Compromise, Elevated Interleukin 1β, Interleukin 1 Receptor Antagonist, and Granulocyte Colony-Stimulating Factor Levels Are Markers of Poor Prognosis
by: Griffiths, Michael J., et al.
Published: (2012)

The role of cell surface heparan sulfate in enterovirus A71 infections and the development of antiviral agents targeting viral attachment and RNA translation initiation / Tan Chee Wah
by: Tan, Chee Wah
Published: (2014)